Therapeutic Solutions International adds Nano Cannabidiol to NanoMyros for Inhibition of Microvesicle and Exosome Release in Prostate Cancer
15 juil. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Therapeutic Solutions International, Inc. (OTC Markets: TSOI) announced today the addition of nano particle cannabidiol to NanoMyros in the form...
Therapeutic Solutions International Develops Adjuvant Technology to Enhance Prostate Cancer Suppressing Properties of NanoPSA
11 juil. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the further development of a mustard seed...
Therapeutic Solutions International Develops Glucoraphanin + NanoStilbene Encapsulated product for reduction of Prostate Specific Antigen (PSA)
08 juil. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today the development of a broccoli sprout extract...